Lexicon Pharmaceuticals's total assets for Q1 2025 were $297.67M, a decrease of -0.25% from the previous quarter. LXRX total liabilities were $174.64M for the fiscal quarter, a 14.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.